Provided by Tiger Trade Technology Pte. Ltd.

Aytu BioScience, Inc.

2.03
-0.0250-1.22%
Post-market: 2.160.1378+6.80%17:22 EDT
Volume:10.53K
Turnover:21.42K
Market Cap:22.01M
PE:-1.75
High:2.07
Open:2.04
Low:2.02
Close:2.05
52wk High:3.07
52wk Low:1.80
Shares:10.87M
Float Shares:8.88M
Volume Ratio:0.47
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1600
EPS(LYR):-1.1600
ROE:-52.55%
ROA:-4.54%
PB:0.62
PE(LYR):-1.75

Loading ...

Jun 16, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 07, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 06, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 27, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 22, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 01, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 19, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]